Related Experiment Video

Updated: Apr 28, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K

GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?

Matthew G Field1, J William Harbour1

  • 1Ocular Oncology Service, Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Cancer Cell
|June 18, 2014
PubMed

Insights

Mutations in GNAQ and GNA11 genes drive uveal melanoma. These oncogenic mutations activate YAP, offering a potential new therapeutic strategy for this difficult-to-treat cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • GNAQ and GNA11 mutations are common drivers in uveal melanoma.
  • Targeting these mutated genes presents significant therapeutic challenges.

Purpose of the Study:

  • To investigate the downstream mechanisms of oncogenic GNAQ/11.
  • To identify potential new therapeutic strategies for uveal melanoma.

Main Methods:

  • The study involved analysis of GNAQ/11 signaling pathways.
  • Investigated the role of YAP in mediating oncogenic activity.

Main Results:

  • Oncogenic activity of mutant GNAQ/11 is significantly mediated by YAP.
  • Demonstrated a link between GNAQ/11 mutations and YAP activation.

Conclusions:

  • YAP is a key mediator of GNAQ/11-driven oncogenesis in uveal melanoma.
  • Targeting the GNAQ/11-YAP axis represents a promising therapeutic avenue.

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

10.4K
Culturing and Manipulation of O9-1 Neural Crest Cells08:32

Culturing and Manipulation of O9-1 Neural Crest Cells

Published on: October 9, 2018

10.5K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K